<?xml version="1.0" encoding="UTF-8"?>
<!--Sample XML file generated by XMLSpy v2008 rel. 2 sp2 (http://www.altova.com)-->
<?altova_sps SemiStructured.sps?>
<Guideline xmlns:sch="http://www.ascc.net/xml/schematron" xmlns:mif="urn:hl7-org:v3/mif" xsi:noNamespaceSchemaLocation="ssrecommendation.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<Metadata>
		<coverage>
			<focus>patient</focus>
			<description>adult</description>
			<type>inclusion</type>
		</coverage>
		<coverage>
			<focus>careSetting</focus>
			<description>outpatient</description>
			<type>inclusion</type>
		</coverage>
		<contributor>
			<roleType>Developer</roleType>
			<organization>
				<name>PHS</name>
			</organization>
		</contributor>
		<identity>
			<title>Aspirin therapy in CAD guideline for AHRQ CDSC pilot</title>
			<description>Rules for initiating aspirin therapy for adult patients for the prevention of coronary artery disease (CAD) </description>
		</identity>
		<evidenceBasis>
			<qualityOfEvidence/>
			<strengthOfRecommendation>USPSTF Grade A</strengthOfRecommendation>
			<supportingReference>
				<title>Aspirin for the Prevention of Cardiovascular Disease  
Release Date: March 2009
 
</title>
				<description>http://cdsportal.partners.org/content/USPSTF-Aspirin-for-the-Prevention-of-Cardiovascular-Disease-L1-L1-1.0-090221fe8001477c.mht </description>
			</supportingReference>
		</evidenceBasis>
	</Metadata>
	<ApplicableScenario>
		<title>Patient Focus per USDA guidelines</title>
		<description>This guideline applies to adult patients (Male 45-79 and Female 55-79) </description>
		<Definition>
			<title>Adult patients </title>
			<description>Males 45-79 and Female 55-79</description>
		</Definition>
	</ApplicableScenario>
	<module>
		<title>MANAGE</title>
		<description>Rules to initiate aspirin therapy for adult patients.</description>
		<Recommendation>
			<title>Consider AspirinTherapy (Not on Aspirin)</title>
			<description>Start aspirin in patients who are not already taking one when the potential benefit due to a reduction in myocardial infarction outweighs the potential harm due to an increase in gastrointestinal hemorrhage</description>
			<recommendedAction>
				<Choice>
					<title>Start aspirin therapy</title>
					<description>Start aspirin therapy</description>
					<choice>
						<indicatedAction>
							<Simple>
								<title>Start aspirin</title>
								<description>Start aspirin</description>
							</Simple>
						</indicatedAction>
					</choice>
				</Choice>
			</recommendedAction>
			<ApplicableScenario>
				<title>Patient not receiving aspirin </title>
				<description>Patient not receiving aspirin </description>
				<Definition>
					<title>Patient not on aspirin</title>
					<description>Patient is not currently on aspirin therapy</description>
				</Definition>
				<Definition>
					<title>No Contraindications to aspirin are present</title>
					<description>Patient has none of the following contraindications (an allergy, or an interacting drug or disease state) that makes aspirin therapy potentially unsafe</description>
				</Definition>
			</ApplicableScenario>
		</Recommendation>
	</module>
</Guideline>
